Health News

US Government Delivers 2, 1 Million Bottles Of TLD To Zim

January 10, 2020 Michael Gwarisa

THE United States Government through USAID’s supply chain and procurement project has delivered 2, 1 million bottles of Tenofovir-Lamivudine-Dolutegravir (TLD) to Zimbabwe. By Kudakwashe Pembere Zimbabwe transitioned to this new regimen with the Dolutegravir component in May 2018 said to have less side effects than Efavirenz. The United States Government USAID’s supply chain and procurement

Features

Demystifying Dolutegravir based antiretroviral drug regimens

May 20, 2019 Michael Gwarisa

ZIMBABWE recently joined other nations to adopt the new HIV treatment regimens that contain Dolutegravir (DTG). The complete transition process for Zimbabwe however, will not take less than 10 months to be fully implemented considering that the country has over a million people on first line HIV medicines. By Michael Gwarisa and Dr. Simbarashe Mabaya

Health News

Zim Commences DTG Drug Transition

May 6, 2019 Michael Gwarisa

DEPUTY Director HIV/AIDS and STIs in the ministry of health and child care (MoHCC), Dr Tsitsi Apollo says the country has already commenced its transition process from Tenovir/Lamuvidene/Efavirens to Dolutegravir (DTG), a first line regimen of Antiretroviral Therapy (ART) which has less side effected and a rapid viral suppression. By Michael Gwarisa The whole transition